Technologies for the therapeutic ablation of tissues are diverse — from ultrasound to electrical, light to radiation — but their common function is to cause the controlled destruction of tissue, either for its excision or simply to remove its aberrant function (as in arrhythmia).
The uptake of the different ablation technologies in clinical practice is driven by the relevance of specific energy types for specific tissue types, the ability to avoid collateral tissue damage, clinician acceptance of manufacturers’ equipment and devices and a variety of other factors.
Technologies for the therapeutic ablation of tissues are diverse — from ultrasound to electrical, light to radiation — but their common function is to cause the controlled destruction of tissue, either for its excision or simply to remove its aberrant function (as in arrhythmia).
The uptake of the different ablation technologies in clinical practice is driven by the relevance of specific energy types for specific tissue types, the ability to avoid collateral tissue damage, clinician acceptance of manufacturers’ equipment and devices and a variety of other factors.
The resulting size of the different ablation market segments, and their growth, is a result of both the historical success each has had in clinical practice and the degree to which these are trending toward continued uptake in therapeutic ablation.
Source: MedMarket Diligence, LLC; Report #A145, “Ablation Technologies Worldwide Market, 2009-2019: Products, Technologies, Markets, Companies and Opportunities.”
